6 Biotechnology Stocks Flush With Cash, Stamped As Strong Buys

Biotech companies can be high risk, high reward investments. They can also consume lots of cash. The companies with war chests of cash are at a huge advantage because that money can fuel ground-breaking research and innovation, or strategic investments that could lead to long term growth. Focusing in on companies with cash, we honed our screen on only those biotech companies that have received 'Strong Buy' ratings from analysts. We think you'll like the list we came up with.The Current ratio is a liquidity ratio used to determine a company's financial health. The metric illustrates how easily a firm can pay back its short obligations all at once through current assets. A company that has a current ratio of one or less is generally a liquidity red flag. Now this doesn't mean the company will go bankrupt tomorrow, but it also doesn't bode well for the company, and
... Read the rest at SeekingAlpha.com